Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 randomized double-blind placebo-controlled study of MHAA4549A plus oseltamivir in hospitalized adults with severe influenza A
MOH_2017-05-14_000417Phase 2Recruiting
- Sponsor
- Genentech
- Start
- Aug 2016
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of vedolizumab in Influenza A infection (3 arms), sponsored by Genentech. Started Aug 2016; status: recruiting.
02
Drugs
vedolizumab
03
Conditions
Influenza A infection
Beyond the preview
Go deeper on MOH_2017-05-14_000417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2017-05-14_000417.